{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T05:28:45Z","timestamp":1782624525964,"version":"3.54.5"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1038\/s41401-025-01747-9","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T14:08:53Z","timestamp":1770300533000},"page":"1422-1435","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Rebalancing the inflammatory trajectory from inflammatory bowel disease to colitis-associated colorectal cancer via artemisinin-based multitarget therapy"],"prefix":"10.1038","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9207-3631","authenticated-orcid":false,"given":"Shi-jun","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7957-3609","authenticated-orcid":false,"given":"Mei-lin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4040-1028","authenticated-orcid":false,"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0900-9568","authenticated-orcid":false,"given":"Jian-ping","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0441-7500","authenticated-orcid":false,"given":"Han-chen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3665-874X","authenticated-orcid":false,"given":"Ze-min","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"1747_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103498","volume":"23","author":"S Wang","year":"2024","unstructured":"Wang S, Dong Z, Wan X. Global, regional, and national burden of inflammatory bowel disease and its associated anemia, 1990 to 2019 and predictions to 2050: an analysis of the global burden of disease study 2019. Autoimmun Rev. 2024;23:103498.","journal-title":"Autoimmun Rev"},{"key":"1747_CR2","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1056\/NEJM199011013231802","volume":"323","author":"A Ekbom","year":"1990","unstructured":"Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. a population-based study. N Engl J Med. 1990;323:1228\u201333.","journal-title":"N Engl J Med"},{"key":"1747_CR3","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S2468-1253(20)30005-4","volume":"5","author":"O Ol\u00e9n","year":"2020","unstructured":"Ol\u00e9n O, Erichsen R, Sachs MC, Pedersen L, Halfvarson J, Askling J, et al. Colorectal cancer in Crohn\u2019s disease: a Scandinavian population-based cohort study. Lancet Gastroenterol Hepatol. 2020;5:475\u201384.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1747_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2024.101074","volume":"15","author":"B Wang","year":"2025","unstructured":"Wang B, Guo X, Qin L, He L, Li J, Jin X, et al. Pharmacological modulation of mitochondrial function as novel strategies for treating intestinal inflammatory diseases and colorectal cancer. J Pharm Anal. 2025;15:101074.","journal-title":"J Pharm Anal"},{"key":"1747_CR5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10555-022-10028-4","volume":"41","author":"H Nagao-Kitamoto","year":"2022","unstructured":"Nagao-Kitamoto H, Kitamoto S, Kamada N. Inflammatory bowel disease and carcinogenesis. Cancer Metastasis Rev. 2022;41:301\u201316.","journal-title":"Cancer Metastasis Rev"},{"key":"1747_CR6","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1053\/j.gastro.2021.10.035","volume":"162","author":"SC Shah","year":"2022","unstructured":"Shah SC, Itzkowitz SH. Colorectal cancer in inflammatory bowel disease: mechanisms and management. Gastroenterology. 2022;162:715\u2013e3.","journal-title":"Gastroenterology"},{"key":"1747_CR7","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/s41577-021-00534-x","volume":"21","author":"M Schmitt","year":"2021","unstructured":"Schmitt M, Greten FR. The inflammatory pathogenesis of colorectal cancer. Nat Rev Immunol. 2021;21:653\u201367.","journal-title":"Nat Rev Immunol"},{"key":"1747_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154824","volume":"115","author":"A Fernandes","year":"2023","unstructured":"Fernandes A, Rodrigues PM, Pintado M, Tavaria FK. A systematic review of natural products for skin applications: targeting inflammation, wound healing, and photo-aging. Phytomedicine. 2023;115:154824.","journal-title":"Phytomedicine"},{"key":"1747_CR9","doi-asserted-by":"crossref","unstructured":"Okombo J, Fidock DA. Towards next-generation treatment options to combat Plasmodium falciparum malaria. Nat Rev Microbiol. 2025:23:178\u201391.","DOI":"10.1038\/s41579-024-01099-x"},{"key":"1747_CR10","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1002\/med.22001","volume":"44","author":"X Gao","year":"2024","unstructured":"Gao X, Lin X, Wang Q, Chen J. Artemisinins: promising drug candidates for the treatment of autoimmune diseases. Med Res Rev. 2024;44:867\u201391.","journal-title":"Med Res Rev"},{"key":"1747_CR11","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1021\/acs.jmedchem.3c01989","volume":"67","author":"Y Geng","year":"2024","unstructured":"Geng Y, Li W, Wong NK, Xue F, Li Q, Zhang Y, et al. Discovery of artemisinins as microsomal prostaglandins synthase-2 inhibitors for the treatment of colorectal cancer via chemoproteomics. J Med Chem. 2024;67:2083\u201394.","journal-title":"J Med Chem"},{"key":"1747_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11033-024-10202-7","volume":"52","author":"SK Jhade","year":"2025","unstructured":"Jhade SK, Kalidoss K, Pathak PK, Shrivastava R. Artemisinin\u2019s molecular symphony: illuminating pathways for cancer therapy. Mol Biol Rep. 2025;52:95.","journal-title":"Mol Biol Rep"},{"key":"1747_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113399","volume":"153","author":"Z-M Lin","year":"2022","unstructured":"Lin ZM, Chen L, Cheng MN, Zhu FH, Yang XQ, Zhao WM, et al. Cortex periplocae modulates the gut microbiota to restrict colitis and colitis-associated colorectal cancer via suppression of pathogenic Th17 cells. Biomed Pharmacother. 2022;153:113399.","journal-title":"Biomed Pharmacother"},{"key":"1747_CR14","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s11427-024-2550-4","volume":"67","author":"S He","year":"2024","unstructured":"He S, Zuo J, Lin Z. Mitigating gut immune adverse effects in CTLA-4 blockade for antitumor efficacy. Sci China Life Sci. 2024;67:1539\u201341.","journal-title":"Sci China Life Sci"},{"key":"1747_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.524","volume":"5","author":"SJ He","year":"2024","unstructured":"He SJ, Zuo JP, Lin ZM. Interplay of IL-17A\/IL-17RA signaling with microbial homeostasis in systemic anti-tumoral responses. MedComm. 2024;5:e524.","journal-title":"MedComm"},{"key":"1747_CR16","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.scib.2023.05.024","volume":"68","author":"S-J He","year":"2023","unstructured":"He SJ, Yang F, Zuo JP, Lin ZM. Fine-tuning immunity against cancer: The emergence of engineered commensal microbiota. Sci Bull. 2023;68:1235\u20137.","journal-title":"Sci Bull"},{"key":"1747_CR17","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3892\/ijo.2012.1747","volume":"42","author":"YJ Du","year":"2013","unstructured":"Du YJ, Lin ZM, Zhao YH, Feng XP, Wang CQ, Wang G, et al. Stability of the recombinant anti\u2011erbB2 scFv\u2011Fc\u2011interleukin\u20112 fusion protein and its inhibition of HER2\u2011overexpressing tumor cells. Int J Oncol. 2013;42:507\u201316.","journal-title":"Int J Oncol"},{"key":"1747_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.eng.2018.11.011","volume":"5","author":"J Wang","year":"2019","unstructured":"Wang J, Xu C, Wong YK, Li Y, Liao F, Jiang T, et al. Artemisinin, the magic drug discovered from traditional Chinese medicine. Engineering. 2019;5:32\u20139.","journal-title":"Engineering"},{"key":"1747_CR19","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1111\/bph.70086","volume":"182","author":"F Zhou","year":"2025","unstructured":"Zhou F, Li G, Tan R, Wu G, Deng C. Artemisinins in autoimmune diseases: effects and mechanisms in systemic lupus erythematosus and rheumatoid arthritis. Br J Pharm. 2025;182:3411\u201327.","journal-title":"Br J Pharm"},{"key":"1747_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep38115","volume":"6","author":"Z-M Lin","year":"2016","unstructured":"Lin ZM, Yang XQ, Zhu FH, He SJ, Tang W, Zuo JP. Artemisinin analogue SM934 attenuate collagen-induced arthritis by suppressing T follicular helper cells and T helper 17 cells. Sci Rep. 2016;6:1\u201311.","journal-title":"Sci Rep"},{"key":"1747_CR21","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1007\/s11427-020-1840-1","volume":"64","author":"Z-M Lin","year":"2021","unstructured":"Lin ZM, Liu YT, Chen L, Cao SQ, Huang YT, Yang XQ, et al. Artemisinin analogue SM934 protects against lupus-associated antiphospholipid syndrome via activation of Nrf2 and its targets. Sci China Life Sci. 2021;64:1702\u201319.","journal-title":"Sci China Life Sci"},{"key":"1747_CR22","doi-asserted-by":"crossref","unstructured":"Shao MJ, Yan YX, Zhu FH, Yang XQ, Qi Q, Yang FM, et al. Artemisinin analog SM934 alleviates epithelial barrier dysfunction via inhibiting apoptosis and caspase-1-mediated pyroptosis in experimental colitis. Front Pharmacol. 2022;13:849014.","DOI":"10.3389\/fphar.2022.849014"},{"key":"1747_CR23","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1360\/N972017-00197","volume":"62","author":"M-Y Zheng","year":"2017","unstructured":"Zheng MY, Liu G, Tang W, Zuo JP, Zhang A, Jiang HL. Structure-activity relationships of the antimalarial agent artemisinin and the research progress on the artemisin in analogues with novel pharmacological actions (in Chinese). Chin Sci Bul. 2017;62:1948\u201363.","journal-title":"Chin Sci Bul."},{"key":"1747_CR24","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41392-023-01413-8","volume":"8","author":"S-J He","year":"2023","unstructured":"He SJ, Ding HH, Chen L, Shen YW, Liu YT, Zhu FH, et al. Repression of interferon regulatory factor-4 (IRF4) hyperactivation restricts murine lupus. Signal Transduct Target Ther. 2023;8:188.","journal-title":"Signal Transduct Target Ther."},{"key":"1747_CR25","doi-asserted-by":"publisher","first-page":"e32424","DOI":"10.1371\/journal.pone.0032424","volume":"7","author":"LF Hou","year":"2012","unstructured":"Hou LF, He SJ, Li X, Wan CP, Yang Y, Zhang XH, et al. SM934 treated lupus-prone NZB \u00d7 NZW F1 mice by enhancing macrophage interleukin-10 production and suppressing pathogenic T cell development. PLoS One. 2012;7:e32424.","journal-title":"PLoS One"},{"key":"1747_CR26","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/435713","volume":"2015","author":"C Shi","year":"2015","unstructured":"Shi C, Li H, Yang Y, Hou L. Anti-inflammatory and immunoregulatory functions of artemisinin and its derivatives. Mediators Inflamm. 2015;2015:435713.","journal-title":"Mediators Inflamm"},{"key":"1747_CR27","doi-asserted-by":"publisher","first-page":"e74108","DOI":"10.1371\/journal.pone.0074108","volume":"8","author":"X Li","year":"2013","unstructured":"Li X, Li TT, Zhang XH, Hou LF, Yang XQ, Zhu FH, et al. Artemisinin analogue SM934 ameliorates murine experimental autoimmune encephalomyelitis through enhancing the expansion and functions of regulatory T cell. PLoS One. 2013;8:e74108.","journal-title":"PLoS One"},{"key":"1747_CR28","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41401-020-0484-5","volume":"42","author":"FM Yang","year":"2021","unstructured":"Yang FM, Fan D, Yang XQ, Zhu FH, Shao MJ, Li Q, et al. The artemisinin analog SM934 alleviates dry eye disease in rodent models by regulating TLR4\/NF-\u03baB\/NLRP3 signaling. Acta Pharmacol Sin. 2021;42:593\u2013603.","journal-title":"Acta Pharmacol Sin"},{"key":"1747_CR29","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/abbs\/gmab097","volume":"53","author":"M Jiang","year":"2021","unstructured":"Jiang M, Zhong G, Zhu Y, Wang L, He Y, Sun Q, et al. Retardant effect of dihydroartemisinin on ulcerative colitis in a JAK2\/STAT3-dependent manner. Acta Biochim Biophys Sin. 2021;53:1113\u201323.","journal-title":"Acta Biochim Biophys Sin"},{"key":"1747_CR30","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/aps.2017.10","volume":"38","author":"XJ Kang","year":"2017","unstructured":"Kang XJ, Wang HY, Peng HG, Chen BF, Zhang WY, Wu AH, et al. Codelivery of dihydroartemisinin and doxorubicin in mannosylated liposomes for drug-resistant colon cancer therapy. Acta Pharmacol Sin. 2017;38:885\u201396.","journal-title":"Acta Pharmacol Sin"},{"key":"1747_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202403461","volume":"11","author":"P Qiu","year":"2024","unstructured":"Qiu P, Chang Y, Chen X, Wang S, Nie H, Hong Y, et al. Dihydroartemisinin modulates enteric glial cell heterogeneity to alleviate colitis. Adv Sci. 2024;11:e2403461.","journal-title":"Adv Sci"},{"key":"1747_CR32","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.bbrc.2018.05.026","volume":"501","author":"Z Yao","year":"2018","unstructured":"Yao Z, Bhandari A, Wang Y, Pan Y, Yang F, Chen R, et al. Dihydroartemisinin potentiates antitumor activity of 5-fluorouracil against a resistant colorectal cancer cell line. Biochem Biophys Res Commun. 2018;501:636\u201342.","journal-title":"Biochem Biophys Res Commun"},{"key":"1747_CR33","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/1415809","volume":"2019","author":"N Li","year":"2019","unstructured":"Li N, Sun W, Zhou X, Gong H, Chen Y, Chen D, et al. Dihydroartemisinin protects against dextran sulfate sodium-induced colitis in mice through inhibiting the PI3K\/AKT and NF-\u03baB signaling pathways. Biomed Res Int. 2019;2019:1415809.","journal-title":"Biomed Res Int"},{"key":"1747_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.103915","volume":"100","author":"Z Lei","year":"2020","unstructured":"Lei Z, Yang Y, Liu S, Lei Y, Yang L, Zhang X, et al. Dihydroartemisinin ameliorates dextran sulfate sodium induced inflammatory bowel diseases in mice. Bioorg Chem. 2020;100:103915.","journal-title":"Bioorg Chem"},{"key":"1747_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216596","volume":"582","author":"X Dai","year":"2024","unstructured":"Dai X, Chen W, Qiao Y, Chen X, Chen Y, Zhang K, et al. Dihydroartemisinin inhibits the development of colorectal cancer by GSK-3\u03b2\/TCF7\/MMP9 pathway and synergies with capecitabine. Cancer Lett. 2024;582:216596.","journal-title":"Cancer Lett"},{"key":"1747_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.127680","volume":"254","author":"Y Tao","year":"2024","unstructured":"Tao Y, Xu L, Liu X, Wang P, Wei S, Huang Y, et al. Chitosan-coated artesunate protects against ulcerative colitis via STAT6-mediated macrophage M2 polarization and intestinal barrier protection. Int J Biol Macromol. 2024;254:127680.","journal-title":"Int J Biol Macromol"},{"key":"1747_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202401126","volume":"13","author":"Q Su","year":"2024","unstructured":"Su Q, Wang Z, Li P, Wei X, Xiao J, Duan X. pH and ROS dual-responsive autocatalytic release system potentiates immunotherapy of colorectal cancer. Adv Health Mater. 2024;13:e2401126.","journal-title":"Adv Health Mater"},{"key":"1747_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121315","volume":"280","author":"W Han","year":"2022","unstructured":"Han W, Duan X, Ni K, Li Y, Chan C, Lin W. Co-delivery of dihydroartemisinin and pyropheophorbide-iron elicits ferroptosis to potentiate cancer immunotherapy. Biomaterials. 2022;280:121315.","journal-title":"Biomaterials"},{"key":"1747_CR39","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00280-023-04623-7","volume":"93","author":"CZ Wang","year":"2024","unstructured":"Wang CZ, Wan C, Li CH, Liang GG, Luo Y, Zhang CF, et al. Ruthenium-dihydroartemisinin complex: a promising new compound for colon cancer prevention via G1 cell cycle arrest, apoptotic induction, and adaptive immune regulation. Cancer Chemother Pharm. 2024;93:411\u201325.","journal-title":"Cancer Chemother Pharm"},{"key":"1747_CR40","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11095-020-02819-7","volume":"37","author":"CD Phung","year":"2020","unstructured":"Phung CD, Le TG, Nguyen VH, Vu TT, Nguyen HQ, Kim JO, et al. PEGylated-Paclitaxel and dihydroartemisinin nanoparticles for simultaneously delivering paclitaxel and dihydroartemisinin to colorectal cancer. Pharm Res. 2020;37:129.","journal-title":"Pharm Res."},{"key":"1747_CR41","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.3390\/biomedicines10112713","volume":"10","author":"Z Pirali-Hamedani","year":"2022","unstructured":"Pirali-Hamedani Z, Abbasi A, Hassan ZM. Synthesis of artemether-loaded albumin nanoparticles and measurement of their anti-cancer effects. Biomedicines. 2022;10:2713.","journal-title":"Biomedicines"},{"key":"1747_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.125163","volume":"244","author":"J Peng","year":"2023","unstructured":"Peng J, Zhou J, Sun R, Chen Y, Pan D, Wang Q, et al. Dual-targeting of artesunate and chloroquine to tumor cells and tumor-associated macrophages by a biomimetic PLGA nanoparticle for colorectal cancer treatment. Int J Biol Macromol. 2023;244:125163.","journal-title":"Int J Biol Macromol"},{"key":"1747_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.carres.2015.04.021","volume":"412","author":"XS Gong","year":"2015","unstructured":"Gong XS, Jiang RJ, Liao XL, Xie HD, Ma X, Gao CZ, et al. Synthesis, characterization and in vitro evaluation of a series of novel polyrotaxane-based delivery system for artesunate. Carbohydr Res. 2015;412:7\u201314.","journal-title":"Carbohydr Res"},{"key":"1747_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109431","volume":"113","author":"L Hua","year":"2022","unstructured":"Hua L, Liang S, Zhou Y, Wu X, Cai H, Liu Z, et al. Artemisinin-derived artemisitene blocks ROS-mediated NLRP3 inflammasome and alleviates ulcerative colitis. Int Immunopharmacol. 2022;113:109431.","journal-title":"Int Immunopharmacol"},{"key":"1747_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155263","volume":"124","author":"H Chen","year":"2024","unstructured":"Chen H, Hu Q, Wen T, Luo L, Liu L, Wang L, et al. Arteannuin B, a sesquiterpene lactone from Artemisia annua, attenuates inflammatory response by inhibiting the ubiquitin-conjugating enzyme UBE2D3-mediated NF-\u03baB activation. Phytomedicine. 2024;124:155263.","journal-title":"Phytomedicine"},{"key":"1747_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115682","volume":"168","author":"M Baggieri","year":"2023","unstructured":"Baggieri M, Gioacchini S, Borgonovo G, Catinella G, Marchi A, Picone P, et al. Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2. Biomed Pharmacother. 2023;168:115682.","journal-title":"Biomed Pharmacother"},{"key":"1747_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1013500","volume":"12","author":"KB Mir","year":"2022","unstructured":"Mir KB, Faheem MM, Ahmad SM, Rasool JU, Amin T, Chakraborty S, et al. \u03b2-(4-fluorobenzyl) Arteannuin B induced interaction of ATF-4 and C\/EBP\u03b2 mediates the transition of breast cancer cells from autophagy to senescence. Front Oncol. 2022;12:1013500.","journal-title":"Front Oncol"},{"key":"1747_CR48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.autrev.2013.06.004","volume":"13","author":"A Geremia","year":"2014","unstructured":"Geremia A, Biancheri P, Allan P, Corazza GR, Di Sabatino A. Innate and adaptive immunity in inflammatory bowel disease. Autoimmun Rev. 2014;13:3\u201310.","journal-title":"Autoimmun Rev"},{"key":"1747_CR49","doi-asserted-by":"crossref","unstructured":"Saez A, Herrero-Fernandez B, Gomez-Bris R, S\u00e1nchez-Martinez H, Gonzalez-Granado JM. Pathophysiology of inflammatory bowel disease: innate immune system. Int J Mol Sci. 2023;24:1526.","DOI":"10.3390\/ijms24021526"},{"key":"1747_CR50","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00384-024-04748-y","volume":"39","author":"VK Shahgoli","year":"2024","unstructured":"Shahgoli VK, Noorolyai S, Ahmadpour Youshanlui M, Saeidi H, Nasiri H, Mansoori B, et al. Inflammatory bowel disease, colitis, and cancer: unmasking the chronic inflammation link. Int J Colorectal Dis. 2024;39:173.","journal-title":"Int J Colorectal Dis"},{"key":"1747_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1338918","volume":"14","author":"H Zhang","year":"2023","unstructured":"Zhang H, Shi Y, Lin C, He C, Wang S, Li Q, et al. Overcoming cancer risk in inflammatory bowel disease: new insights into preventive strategies and pathogenesis mechanisms including interactions of immune cells, cancer signaling pathways, and gut microbiota. Front Immunol. 2023;14:1338918.","journal-title":"Front Immunol"},{"key":"1747_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01386-9","volume":"21","author":"K Zhang","year":"2023","unstructured":"Zhang K, Guo J, Yan W, Xu L. Macrophage polarization in inflammatory bowel disease. Cell Commun Signal. 2023;21:367.","journal-title":"Cell Commun Signal"},{"key":"1747_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116930","volume":"177","author":"W Zhang","year":"2024","unstructured":"Zhang W, Wang M, Ji C, Liu X, Gu B, Dong T. Macrophage polarization in the tumor microenvironment: Emerging roles and therapeutic potentials. Biomed Pharmacother. 2024;177:116930.","journal-title":"Biomed Pharmacother"},{"key":"1747_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1545468","volume":"16","author":"S Yin","year":"2025","unstructured":"Yin S, Li L, Chen X, Wang J, Mao Y, Wang J, et al. Artesunate alleviated murine ulcerative colitis by regulating immune response through inhibiting endoplasmic reticulum stress. Front Immunol. 2025;16:1545468.","journal-title":"Front Immunol"},{"key":"1747_CR55","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1038\/aps.2017.185","volume":"39","author":"YX Yan","year":"2018","unstructured":"Yan YX, Shao MJ, Qi Q, Xu YS, Yang XQ, Zhu FH, et al. Artemisinin analogue SM934 ameliorates DSS-induced mouse ulcerative colitis via suppressing neutrophils and macrophages. Acta Pharmacol Sin. 2018;39:1633\u201344.","journal-title":"Acta Pharmacol Sin"},{"key":"1747_CR56","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s10787-019-00678-2","volume":"28","author":"W Sun","year":"2020","unstructured":"Sun W, Han X, Wu S, Wu J, Yang C, Li X. Unexpected mechanism of colitis amelioration by artesunate, a natural product from Artemisia annua L. Inflammopharmacology. 2020;28:851\u201368.","journal-title":"Inflammopharmacology"},{"key":"1747_CR57","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.cmet.2025.01.007","volume":"37","author":"Z Wang","year":"2025","unstructured":"Wang Z, Tian L, Jiang Y, Ning L, Zhu X, Chen X, et al. Synergistic role of gut-microbial L-ornithine in enhancing ustekinumab efficacy for Crohn\u2019s disease. Cell Metab. 2025;37:1089\u2013e7.","journal-title":"Cell Metab"},{"key":"1747_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(25)00071-8","volume":"10","author":"BG Feagan","year":"2025","unstructured":"Feagan BG, Sands BE, Siegel CA, Dubinsky MC, Longman RS, Sabino J, et al. Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn\u2019s disease: a phase 2a induction trial. Lancet Gastroenterol Hepatol. 2025;10:e10.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1747_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.103017","volume":"21","author":"H Nakase","year":"2022","unstructured":"Nakase H, Sato N, Mizuno N, Ikawa Y. The influence of cytokines on the complex pathology of ulcerative colitis. Autoimmun Rev. 2022;21:103017.","journal-title":"Autoimmun Rev"},{"key":"1747_CR60","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.7150\/thno.96184","volume":"14","author":"Y Cai","year":"2024","unstructured":"Cai Y, Li S, Yang Y, Duan S, Fan G, Bai J, et al. Intestinal epithelial damage-derived mtDNA activates STING-IL12 axis in dendritic cells to promote colitis. Theranostics. 2024;14:4393\u2013410.","journal-title":"Theranostics"},{"key":"1747_CR61","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1136\/gutjnl-2019-319850","volume":"69","author":"JN Clough","year":"2020","unstructured":"Clough JN, Omer OS, Tasker S, Lord GM, Irving PM. Regulatory T-cell therapy in Crohn\u2019s disease: challenges and advances. Gut. 2020;69:942\u201352.","journal-title":"Gut"},{"key":"1747_CR62","doi-asserted-by":"publisher","first-page":"4258","DOI":"10.1158\/0008-5472.CAN-13-3065","volume":"74","author":"E Pastille","year":"2014","unstructured":"Pastille E, Bardini K, Fleissner D, Adamczyk A, Frede A, Wadwa M, et al. Transient ablation of regulatory T cells improves antitumor immunity in colitis-associated colon cancer. Cancer Res. 2014;74:4258\u201369.","journal-title":"Cancer Res"},{"key":"1747_CR63","doi-asserted-by":"crossref","unstructured":"Yan SC, Wang YJ, Li YJ, Cai WY, Weng XG, Li Q, et al. Dihydroartemisinin regulates the Th\/Treg balance by inducing activated CD4+ T cell apoptosis via heme oxygenase-1 induction in mouse models of inflammatory bowel disease. Molecules. 2019;24:2475.","DOI":"10.3390\/molecules24132475"},{"key":"1747_CR64","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/ddr.21590","volume":"80","author":"VL Kumar","year":"2019","unstructured":"Kumar VL, Verma S, Das P. Artesunate suppresses inflammation and oxidative stress in a rat model of colorectal cancer. Drug Dev Res. 2019;80:1089\u201397.","journal-title":"Drug Dev Res"},{"key":"1747_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1390351","volume":"15","author":"P Muro","year":"2024","unstructured":"Muro P, Zhang L, Li S, Zhao Z, Jin T, Mao F, et al. The emerging role of oxidative stress in inflammatory bowel disease. Front Endocrinol. 2024;15:1390351.","journal-title":"Front Endocrinol"},{"key":"1747_CR66","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1038\/s41401-022-00978-4","volume":"43","author":"X Tong","year":"2022","unstructured":"Tong X, Chen L, He SJ, Zuo JP. Artemisinin derivative SM934 in the treatment of autoimmune and inflammatory diseases: therapeutic effects and molecular mechanisms. Acta Pharmacol Sin. 2022;43:3055\u201361.","journal-title":"Acta Pharmacol Sin"},{"key":"1747_CR67","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1002\/med.21842","volume":"41","author":"T Efferth","year":"2021","unstructured":"Efferth T, Oesch F. The immunosuppressive activity of artemisinin-type drugs towards inflammatory and autoimmune diseases. Med Res Rev. 2021;41:3023\u201361.","journal-title":"Med Res Rev"},{"key":"1747_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2025.102791","volume":"94","author":"M Eldesoqui","year":"2025","unstructured":"Eldesoqui M, Ali LS, Erfan OS, Dawood AF, Badawy AA, Ali SK, et al. Dihydroartemisinin attenuates acetic acid-induced ulcerative colitis in rats: suppression of inflammation and modulation of NF\u03ba\u03b2\/TNF-\u03b1\/RIPK1-mediated necroptosis and apoptosis. Tissue Cell. 2025;94:102791.","journal-title":"Tissue Cell"},{"key":"1747_CR69","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.freeradbiomed.2021.03.024","volume":"168","author":"S Bader","year":"2021","unstructured":"Bader S, Wilmers J, Pelzer M, Jendrossek V, Rudner J. Activation of anti-oxidant Keap1\/Nrf2 pathway modulates efficacy of dihydroartemisinin-based monotherapy and combinatory therapy with ionizing radiation. Free Radic Biol Med. 2021;168:44\u201354.","journal-title":"Free Radic Biol Med"},{"key":"1747_CR70","doi-asserted-by":"publisher","first-page":"102","DOI":"10.4103\/japtr.JAPTR_61_17","volume":"8","author":"S Patyar","year":"2017","unstructured":"Patyar S, Patyar RR, Medhi B, Khanduja KL. Chemopreventive effect of artesunate in 1,2-dimethylhydrazine-induced rat colon carcinogenesis. J Adv Pharm Technol Res. 2017;8:102\u20137.","journal-title":"J Adv Pharm Technol Res"},{"key":"1747_CR71","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1136\/gutjnl-2019-318427","volume":"68","author":"M Camilleri","year":"2019","unstructured":"Camilleri M. Leaky gut: mechanisms, measurement and clinical implications in humans. Gut. 2019;68:1516\u201326.","journal-title":"Gut"},{"key":"1747_CR72","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1136\/gutjnl-2022-328421","volume":"72","author":"H Leibovitzh","year":"2023","unstructured":"Leibovitzh H, Lee SH, Raygoza Garay JA, Espin-Garcia O, Xue M, Neustaeter A, et al. Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn\u2019s disease highlight earliest events of pathogenesis. Gut. 2023;72:1462\u201371.","journal-title":"Gut"},{"key":"1747_CR73","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1136\/gutjnl-2023-331579","volume":"73","author":"M Iacucci","year":"2024","unstructured":"Iacucci M, Santacroce G, Majumder S, Morael J, Zammarchi I, Maeda Y, et al. Opening the doors of precision medicine: novel tools to assess intestinal barrier in inflammatory bowel disease and colitis-associated neoplasia. Gut. 2024;73:1749\u201362.","journal-title":"Gut"},{"key":"1747_CR74","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41575-023-00890-0","volume":"21","author":"MR Aburto","year":"2024","unstructured":"Aburto MR, Cryan JF. Gastrointestinal and brain barriers: unlocking gates of communication across the microbiota-gut-brain axis. Nat Rev Gastroenterol Hepatol. 2024;21:222\u201347.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1747_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107284","volume":"91","author":"M Huai","year":"2021","unstructured":"Huai M, Zeng J, Ge W. Artemisinin ameliorates intestinal inflammation by skewing macrophages to the M2 phenotype and inhibiting epithelial-mesenchymal transition. Int Immunopharmacol. 2021;91:107284.","journal-title":"Int Immunopharmacol"},{"key":"1747_CR76","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s10753-019-01164-1","volume":"43","author":"S Yin","year":"2020","unstructured":"Yin S, Yang H, Tao Y, Wei S, Li L, Liu M, et al. Artesunate ameliorates DSS-induced ulcerative colitis by protecting intestinal barrier and inhibiting inflammatory response. Inflammation. 2020;43:765\u201376.","journal-title":"Inflammation"},{"key":"1747_CR77","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1007\/s11033-021-07079-1","volume":"49","author":"CZ Wang","year":"2022","unstructured":"Wang CZ, Wan C, Luo Y, Zhang CF, Zhang QH, Chen L, et al. Effects of dihydroartemisinin, a metabolite of artemisinin, on colon cancer chemoprevention and adaptive immune regulation. Mol Biol Rep. 2022;49:2695\u2013709.","journal-title":"Mol Biol Rep"},{"key":"1747_CR78","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41575-024-00997-y","volume":"22","author":"R Caruso","year":"2025","unstructured":"Caruso R, Lo BC, Chen GY, Nunez G. Host-pathobiont interactions in Crohn\u2019s disease. Nat Rev Gastroenterol Hepatol. 2025;22:395\u2013414.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1747_CR79","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41575-023-00854-4","volume":"21","author":"JJ Rudbaek","year":"2024","unstructured":"Rudbaek JJ, Agrawal M, Torres J, Mehandru S, Colombel JF, Jess T. Deciphering the different phases of preclinical inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2024;21:86\u2013100.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1747_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116827","volume":"176","author":"PAZ Hasibuan","year":"2024","unstructured":"Hasibuan PAZ, Simanjuntak Y, Hey-Hawkins E, Lubis MF, Rohani AS, Park MN, et al. Unlocking the potential of flavonoids: natural solutions in the fight against colon cancer. Biomed Pharmacother. 2024;176:116827.","journal-title":"Biomed Pharmacother"},{"key":"1747_CR81","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1002\/ddr.22067","volume":"84","author":"Y Wang","year":"2023","unstructured":"Wang Y, Yang Z, Zhu W, Chen Y, He X, Li J, et al. Dihydroartemisinin inhibited stem cell-like properties and enhanced oxaliplatin sensitivity of colorectal cancer via AKT\/mTOR signaling. Drug Dev Res. 2023;84:988\u201398.","journal-title":"Drug Dev Res"},{"key":"1747_CR82","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1258843","volume":"11","author":"DC Macias-Ceja","year":"2023","unstructured":"Macias-Ceja DC, Mendoza-Ballesteros MT, Ortega-Albiach M, Barrachina MD, Ortiz-Masia D. Role of the epithelial barrier in intestinal fibrosis associated with inflammatory bowel disease: relevance of the epithelial-to mesenchymal transition. Front Cell Dev Biol. 2023;11:1258843.","journal-title":"Front Cell Dev Biol"},{"key":"1747_CR83","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3390\/cells14070488","volume":"14","author":"A Nishida","year":"2025","unstructured":"Nishida A, Andoh A. The role of inflammation in cancer: mechanisms of tumor initiation, progression, and metastasis. Cells. 2025;14:488.","journal-title":"Cells"},{"key":"1747_CR84","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/ijc.22804","volume":"121","author":"LN Li","year":"2007","unstructured":"Li LN, Zhang HD, Yuan SJ, Tian ZY, Wang L, Sun ZX. Artesunate attenuates the growth of human colorectal carcinoma and inhibits hyperactive Wnt\/beta-catenin pathway. Int J Cancer. 2007;121:1360\u20135.","journal-title":"Int J Cancer"},{"key":"1747_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2021.109704","volume":"350","author":"M Jiang","year":"2021","unstructured":"Jiang M, Wu Y, Qi L, Li L, Song D, Gan J, et al. Dihydroartemisinin mediating PKM2-caspase-8\/3-GSDME axis for pyroptosis in esophageal squamous cell carcinoma. Chem Biol Interact. 2021;350:109704.","journal-title":"Chem Biol Interact"},{"key":"1747_CR86","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s11427-023-2587-2","volume":"68","author":"Z-M Lin","year":"2025","unstructured":"Lin ZM, Xiang M, Wei WH, Fan SH, Chen L, Wang J, et al. Identification of a dual functional betulinic acid analog for the treatment of osteoarthritis by phenotypic screening. Sci China Life Sci. 2025;68:300\u20132.","journal-title":"Sci China Life Sci"},{"key":"1747_CR87","doi-asserted-by":"publisher","unstructured":"Chang Y, Guo M, Yuan W, Hu Y, Zhu F, Yang X, et al. SNX25-mediated regulation of NGF by Periploca sepium periplosides from Xiangjiapi in macrophage-dependent anti-nociception. Sci China Life Sci. 2025. https:\/\/doi.org\/10.1007\/s11427-025-3007-1","DOI":"10.1007\/s11427-025-3007-1"},{"key":"1747_CR88","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3390\/pharmaceutics17030299","volume":"17","author":"M Shi","year":"2025","unstructured":"Shi M, Ma G, Yang X. Artesunate: a review of its potential therapeutic effects and mechanisms in digestive diseases. Pharmaceutics. 2025;17:299.","journal-title":"Pharmaceutics"},{"key":"1747_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-023-01152-6","volume":"12","author":"Y Huang","year":"2023","unstructured":"Huang Y, Yang Y, Liu G, Xu M. New clinical application prospects of artemisinin and its derivatives: a scoping review. Infect Dis Poverty. 2023;12:115.","journal-title":"Infect Dis Poverty"},{"key":"1747_CR90","doi-asserted-by":"publisher","first-page":"6225","DOI":"10.7150\/thno.55939","volume":"11","author":"B Bai","year":"2021","unstructured":"Bai B, Wu F, Ying K, Xu Y, Shan L, Lv Y, et al. Therapeutic effects of dihydroartemisinin in multiple stages of colitis-associated colorectal cancer. Theranostics. 2021;11:6225\u201339.","journal-title":"Theranostics"},{"key":"1747_CR91","first-page":"1321","volume":"20","author":"YX Chen","year":"2019","unstructured":"Chen YX, Zhang XQ, Yu CG, Huang SL, Xie Y, Dou XT, et al. Artesunate exerts protective effects against ulcerative colitis via suppressing Toll\u2011like receptor 4 and its downstream nuclear factor\u2011\u03baB signaling pathways. Mol Med Rep. 2019;20:1321\u201332.","journal-title":"Mol Med Rep"},{"key":"1747_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106949","volume":"88","author":"R Liang","year":"2020","unstructured":"Liang R, Chen W, Fan H, Chen X, Zhang J, Zhu JS. Dihydroartemisinin prevents dextran sodium sulphate-induced colitisthrough inhibition of the activation of NLRP3 inflammasome and p38 MAPK signaling. Int Immunopharmacol. 2020;88:106949.","journal-title":"Int Immunopharmacol"},{"key":"1747_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109918","volume":"117","author":"J Yu","year":"2023","unstructured":"Yu J, Sheng S, Zou X, Shen Z. Dihydroartemisinin-ursodeoxycholic acid conjugate is a potential treatment agent for inflammatory bowel disease. Int Immunopharmacol. 2023;117:109918.","journal-title":"Int Immunopharmacol"},{"key":"1747_CR94","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s44371-025-00084-4","volume":"2","author":"TA Addissouky","year":"2025","unstructured":"Addissouky TA. Artemisinin and its derivatives throughout the therapeutic mechanisms and clinical potential. Discov Chem. 2025;2:10.","journal-title":"Discov Chem"},{"key":"1747_CR95","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jconrel.2024.10.043","volume":"376","author":"C Yang","year":"2024","unstructured":"Yang C, Ming H, Li B, Liu S, Chen L, Zhang T, et al. A pH and glutathione-responsive carbon monoxide-driven nano-herb delivery system for enhanced immunotherapy in colorectal cancer. J Control Rel. 2024;376:659\u201377.","journal-title":"J Control Rel"},{"key":"1747_CR96","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1007\/s10753-024-02200-5","volume":"48","author":"U Madan","year":"2024","unstructured":"Madan U, Awasthi A. Antimalarial drug artemotil promotes induction of type 1 regulatory t cells. Inflammation. 2024;48:2431\u201343.","journal-title":"Inflammation"},{"key":"1747_CR97","first-page":"787","volume":"39","author":"X Zhu","year":"2023","unstructured":"Zhu X, Li T, Chen Z. Oral administration of artemisinin nanospheres alleviates inflammation in mice with spontaneous ulcerative colitis. Xi Bao Yu Fen Zi Mian Yi. Xue Za Zhi. 2023;39:787\u201392.","journal-title":"Xue Za Zhi"},{"key":"1747_CR98","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6211215","volume":"2022","author":"X Jia","year":"2022","unstructured":"Jia X, Gao Y, Liu L, Guo Y, Wang J, Ma H, et al. Artemisinin alleviates intestinal inflammation and metabolic disturbance in ulcerative colitis rats induced by DSS. Evid Based Complement Altern Med. 2022;2022:6211215.","journal-title":"Evid Based Complement Altern Med"},{"key":"1747_CR99","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.3390\/cells11162472","volume":"11","author":"Z Huang","year":"2022","unstructured":"Huang Z, Gan S, Zhuang X, Chen Y, Lu L, Wang Y, et al. Artesunate inhibits the cell growth in colorectal cancer by promoting ROS-dependent cell senescence and autophagy. Cells. 2022;11:2472.","journal-title":"Cells"},{"key":"1747_CR100","doi-asserted-by":"publisher","first-page":"175","DOI":"10.7150\/ijms.66737","volume":"19","author":"RH Gong","year":"2022","unstructured":"Gong RH, Yang DJ, Kwan HY, Lyu AP, Chen GQ, Bian ZX. Cell death mechanisms induced by synergistic effects of halofuginone and artemisinin in colorectal cancer cells. Int J Med Sci. 2022;19:175\u201385.","journal-title":"Int J Med Sci"},{"key":"1747_CR101","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/13880209.2020.1867196","volume":"59","author":"ZB Yang","year":"2021","unstructured":"Yang ZB, Qiu LZ, Chen Q, Lin JD. Artesunate alleviates the inflammatory response of ulcerative colitis by regulating the expression of miR-155. Pharm Biol. 2021;59:97\u2013105.","journal-title":"Pharm Biol"},{"key":"1747_CR102","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04247-w","volume":"12","author":"X Hu","year":"2021","unstructured":"Hu X, Fatima S, Chen M, Huang T, Chen YW, Gong R, et al. Dihydroartemisinin is potential therapeutics for treating late-stage CRC by targeting the elevated c-Myc level. Cell Death Dis. 2021;12:1053.","journal-title":"Cell Death Dis"},{"key":"1747_CR103","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1093\/carcin\/bgaa084","volume":"42","author":"T Hamoya","year":"2021","unstructured":"Hamoya T, Fujii G, Iizumi Y, Narita T, Komiya M, Matsuzawa Y, et al. Artesunate inhibits intestinal tumorigenesis through inhibiting wnt signaling. Carcinogenesis. 2021;42:148\u201358.","journal-title":"Carcinogenesis"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01747-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01747-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01747-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T09:02:12Z","timestamp":1779440532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01747-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":103,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1747"],"URL":"https:\/\/doi.org\/10.1038\/s41401-025-01747-9","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Prof Jian-ping ZUO\u00a0is the one of the Associate Editors of the journal and was not involved in the peer review or the decision making of the article. The authors declare no other competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}